We present the synthesis of a series of six new glycoluril derived molecular clips and acyclic CB[n]-type molecular containers (1-3) that all feature SO 3 − solubilizing groups but differ in the number of glycoluril rings between the two terminal dialkoxyaromatic sidewalls. We report the X-ray crystal structure of 3b which shows that its dialkoxynaphthalene sidewalls actively define a hydrophobic cavity with high potential to engage in π-π interactions with insoluble aromatic guests. Compounds 1-3 possess very good solubility characteristics (≥38 mM) and undergo only very weak self-association (K s < 92 M −1
Introduction
A ubiquitous problem facing the pharmaceutical industry is that an estimated 40-70% of new drug candidates are so poorly soluble that they cannot be formulated on their own. receptors. 12d,g,j,20 Recently, the Isaacs group used acyclic CB [n] containers as solubilizing excipients 21 for insoluble drugs and reported the influence of the nature of the solubilizing groups 22 and aromatic sidewalls 23 on their function. In this paper we explore the influence of the length of the central glycoluril oligomer on their ability of acyclic CB[n]-type receptors 1-4 to solubilize four insoluble drugs (Fig. 2 ).
Results and discussion
This results and discussion section is organized as follows. First, we present the synthesis of six new containers (1-3), studies of their inherent solubility, and studies of their tendency toward self-association. Next, we present the X-ray crystal structure of 3b and compare it to the X-ray crystal structures of previously reported glycoluril monomer, dimer, and tetramer derived containers. Next, we report the ability of 1-3 to act as solubilizing agents for four insoluble drugs. Finally, we compare the trends in the solubilization data for 1-3 with that of previously reported 4a and 4b.
Synthesis of Containers 1-3
Scheme 1 shows the synthesis of new compounds 1-3. For the preparation of molecular clips 1a and 1b we followed the path blazed by Nolte and co-workers and allowed glycoluril bis(cyclic ether) 1CE to react with the corresponding dialkoxyaromatic walls (5 and 6) at 70°C in TFA-Ac 2 O to deliver molecular clips 1a and 1b in high yield. 21, 24 To prepare molecular clips 2a and 2b we first transformed the known glycoluril dimer 2NH 25 into bis(cyclic ether) 2CE by treatment with paraformaldehyde in TFA at reflux (40%). Subsequently, we reacted 2CE with 5 or 6 in TFA/Ac 2 O at 70°C to yield molecular clips 2a and 2b in good yield. For the preparation of acyclic CB[n] compounds 3a and 3b we first needed to prepare the glycoluril trimer 3CE. The preparation of 3CE was accomplished by reaction of glycoluril (7) with 1CE in methanesulfonic acid with careful temperature control (10°C for 2 h and then 23°C for 2 h). Subsequently, we allowed 3CE to react with 5 or 6 in TFA/ Ac 2 O at 70°C to give 3a (48%) and 3b (59%) in good yields. We were fortunate to obtain the X-ray crystal structure of acyclic CB[n]-type receptor 3b (Fig. 3) . Fig. 3 also shows the X-ray crystal structure of previously prepared molecular clips 1ester and 2ester (Fig. 4 ) and acyclic CB[n]-type receptor 4b to illustrate the geometrical change that occurs across the homologous series of receptors 1-4 upon elongation of the glycoluril oligomer backbone. As can be readily seen, as one increases the number of glycoluril rings the receptors change from molecular clips with divergent to nearly parallel aromatic sidewalls (1 and 2) to containers with a well defined hydrophobic cavity despite their acyclic nature (3 and 4). Overall, as a result of the glycoluril trimer backbone, 3b is C-shaped and the two naphthalene rings help to define a cavity that is occupied by a molecule of acetone in the crystal. The mean planes of the aromatic rings of 3b are oriented at an average angle of 65.5°(range over 4 independent molecules in the crystal: 110.6°to 116.6°) and do not undergo either π-π stacking or edge-to-face CH-π interactions with each other. For example, molecular clips based on glycolurils (e.g. relatives of 1) feature outwardly oriented aromatic rings (35.9°interplanar angle) whereas those based on glycoluril dimers (e.g. relative of 2) feature aromatic rings that are close to parallel to one another (18.3°interplanar angle). In contrast, the X-ray crystal structure of 4b reported previously shows an 113.3°angle between the naphthalene rings and direct CH-π interactions which helps to define a hydrophobic box.
The packing of 3b in the crystal is intriguing (Fig. 5) . Analogous to what is observed for molecular clips based on glycoluril or glycoluril dimers, 28 the individual molecules of 3b interact with one another via CH-π and π-π interactions between their naphthalene sidewalls in a head-to-tail fashion to yield linear tape like assemblies. The distance between the 
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This journal is © The Royal Society of Chemistry 2015 mean planes of the naphthalene ring averages 3.66 Å (range 3.60 to 3.78 Å). These tapes extend along both the b-axis and the c-axis; they are alternately arranged in a criss-cross fashion reminiscent of building method of a log cabin home as one extends along the a-axis. The channels defined by the packing of the linear assemblies are filled with the solubilizing arms and solvating water molecules.
Inherent solubility of 1-4
Given our interest in assessing the performance of 1-3 as solubilizing excipients for insoluble drugs we first sought to measure their inherent solubility. For this purpose, we stir an excess of container with 20 mM phosphate buffered D 2 O and readjust the pD to 7.4 until equilibrium is reached and then remove excess insoluble container by centrifugation and filtration. An aliquot of the filtrate is diluted by a known factor and combined with a solution of benzene-1,3,5-tricarboxylic acid as internal standard (1.00 mM); the relative integrals of diagnostic resonances in the 1 H NMR spectrum for the container (1a: 6.87 ppm, 1b: 7.56 ppm, 2a: 6.99 ppm, 2b: 7.84 ppm, 3a: 7.02 ppm, 3b: 7.95 ppm) versus those of the internal standard (8.38 ppm) were used to determine the inherent solubility of each container. The results are summarized in Table 1 . As can be readily seen, the solubility of all the containers bearing dialkoxy-o-xylylene sidewalls is higher than 100 mM which is advantageous for their use as solubilizing excipients. In contrast, the solubility of containers with naphthalene sidewalls are variable. Containers 2b and 3b display high solubility (>300 mM) whereas 1b and 4b are modest (38 and 14 mM, respectively).
Containers 1-3 do not self-associate strongly
In order for molecular containers to have high potential for use as solubilizing excipients they must not be strongly selfassociated which would reduce their ability to form container drug complexes. Accordingly, we studied the self-association of 1-3 by preparing solutions of different concentrations of 1-3 and monitoring the changes in the 1 H NMR chemical shifts.
The chemical shifts of the protons on the aromatic sidewall were particularly sensitive to self-association. Fig. 6 Fig. 4 . Because the CO 2 − solubilizing groups of 1acid and 2acid are on their convex face, unfavorable carboxylatecarboxylate electrostatic interactions are avoided upon formation of dimers 1acid 2 and 2acid 2 . In contrast, the SO 3 − groups of 1-4 are directed toward each other within the putative dimeric species 1 2 -4 2 which results in unfavorable electrostatic sulfonate-sulfonate interactions which decreases the propensity of 1-4 to dimerize. The self-association constant of 1a (2a) is 61-fold (3500-fold) lower than that measured for 1acid (2acid) which amounts to a destabilization of the dimer by 2.4 (4.8) kcal mol −1 which we attribute to electrostatics. The recognition of the importance of electrostatic interactions that discourage self-association of 1-4 provides a rationale for the superior binding constants observed previously for 4a and 4c relative to 4d 12g,j which lacks the anionic solubilizing groups which translates into the superior solubilizing abilities of 4a and 4b.
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Construction of phase solubility diagrams for 1-3 with insoluble drugs
In order to assess the ability of 1-3 as solubilizing agents for insoluble drugs we created phase solubility diagrams (PSD) 29, 31 for the six new containers 1-3. Phase solubility dia- (1) where S 0 is the inherent solubility of the drug, K a is the binding constant for the container drug complex, and slope is the slope of the PSD. 29 In this paper, we generally observed A L -type PSDs except for 2a and 2b with ziprasidone and 2a with PBS-1086 which displayed A P -type behaviour. We consider PSDs with slopes ≥0.5 (e.g. a 50 mM solution of container solubilizes 25 mM drug) as indication that a given container is a very good solubilizing agent for a given drug. If we substitute slope = 0.5 into eqn (1) then it is easy to show that K a × S 0 = 1. 23 Alternatively, if we want to solubilize a drug with inherent solubility of 1 × 10 −5 M
(1 × 10 −6 M) then the container must display a binding constant of 1 × 10 5 M −1 (1 × 10 6 M −1 ) to achieve a slope of 0.5.
In this section we report the phase solubility behavior of 1-3 with four insoluble drugs (camptothecin, PBS-1086, β-estradiol, and ziprasidone) which we have previously studied with 4a and 4b. 21, 23 To create the PSDs we prepare a solution of container of known concentration and stir it with an excess of solid insoluble drug. After equilibrium is reached, the excess of insoluble drug is removed by centrifugation and filtration. The concentration of drug in the filtrate is determined by 1 H NMR spectroscopy after addition of benzene-1,3,5-tricarboxylic acid (1.00 mM) as a non-binding internal standard using the relative integrals of diagnostic resonances of the drug versus those of the internal standard. Fig. 8a shows the PSDs for solutions of containers 1-4 with the insoluble drug β-estradiol. As can be readily seen most of the PSDs are of the A L -type and it is therefore appropriate to perform a linear fitting of the data to determine the value of the slope. The slope values range from 0 to 0.92 for 4b which indicates that the affinity of the various containers toward β-estradiol differ significantly. Next, we substituted the measured slope values and the known inherent solubilities (S 0 ) 23 into eqn (1) to determine the affinity constant (K a , M −1 ) for the interaction of each container β-estradiol complex (Table 2) . In Table 2 , the values of slope and K a and their uncertainty are given to two significant figures which reflects the limitations of phase solubility measurements. Similar experiments were performed for camptothecin with containers 1-3 and compared with the data previously reported for 4 (Fig. 8b,c and Table 2 ). 21, 23 Fig. 8c shows that the PSD for 4a and camptothecin displays a plateau region above [4a] = 10 mM which reflects the limited solubility 
Interpretation of the trends in the K a values and solubilization efficiency
This section discusses the trends in the K a values as a function of the structural variables of the containers and the guests.
Influence of the number of glycoluril rings. As shown in Fig. 3 , the crystal structures of 1-4 demonstrate that compounds 1 and 2 are molecular clips with divergent and slightly convergent aromatic sidewalls, respectively. In contrast, containers 3 and 4 are more properly defined as acyclic CB[n]-type receptors because they feature more fully formed ureidyl CvO portals and closed cavities that are fully defined by the glycoluril rings and the aromatic sidewalls. Accordingly, it is appropriate to compare the solubilization properties of 1 and 2 and separately, 3 and 4. We find that container 1a is uniformly unsuccessful as a solubilizing agent, whereas container 2a is able to solubilize camptothecin, ziprasidone, and PBS-1086. We attribute the better solubilizing ability of 2a to the more nearly parallel alignment of its aromatic walls (centroid to centroid distance = 7.40 Å) which preorganizes it to engage in π-π interactions with drugs that contain aromatic rings. In contrast, the behavior of containers 1b and 2b toward the four drugs is drug dependent. For example, container 1b performs better for camptothecin and β-estradiol but 2b performs better for ziprasidone and PBS-1086. In this regard it is noteworthy that the PSDs for 2a and 2b with ziprasidone are non-linear which is indicative of higher order container n ·drug complexes.
The behavior of acyclic CB[n]-type containers 3 and 4 toward the four drugs exhibit clear trends. For example, container 3a binds less strongly (K a ≈ 10 3 − 10 4 M −1 ) to all four drugs than 4a does (2.9 × 10 3 < K a < 5.5 × 10 5 M −1 ). We attribute this result to the larger hydrophobic cavity of 4a relative to 3a and the more fully formed ureidyl CvO portals of 4a which results in stronger ion-dipole interactions with cationic drugs (e.g. ziprasidone). Similarly, container 3b (2.0 × 10 3 < K a < 3.6 × 10 4 M −1
does not perform as well as 4b (1.2 × 10 4 < K a < 1.9 × 10 6 M −1 ) as a solubilizing agent for these four drugs. Accordingly, we conclude that container 4 is a more efficient solubilizing agent than container 3 although the relative in vivo efficacy of drugs formulated by the different containers will depend on the ability of the drugs to be released by dilution and competition from endogenous cationic small molecules (e.g. spermine).
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Influence of aromatic sidewall. The influence of the nature of the aromatic sidewall (e.g. benzene versus naphthalene) is clear cut for containers 1, 3, 4. In most cases the containers with the longer aromatic sidewall (e.g. naphthalene) display higher K a values toward the drugs. For example, container 1b binds nicely (K a = 2.2 × 10 4 and 2.6 × 10 3 M −1 ) toward camptothecin and β-estradiol whereas the binding of 1a to these drugs could not be detected. Similarly, the ratio of the K a values of 3b versus 3a toward camptothecin (2.3), ziprasidone (8.2), PBS-1086 (4.9), and β-estradiol (9.3) indicate that 3b is a significantly better host than 3a. Containers 4b and 4a display a similar trend with the ratio of K a values for 4b versus 4a toward camptothecin (>6.4), PBS-1086 (3.5), and β-estradiol (21) . Interestingly, ziprasidone which is both narrow and cationic at pD 7.4 prefers to bind to the smaller cavity of container 4a relative to 4b. We conclude that the containers with substituted naphthalene sidewalls generally outperform those with o-xylylene sidewalls because they possess larger hydrophobic cavities which should increase the number of solvating 
Experimental

General experimental
Starting materials were purchased from commercial suppliers and were used without further purification or were prepared by literature procedures. Compounds 1CE and 2NH were prepared according to literature procedures. 21, 25 Melting points were measured on a Meltemp apparatus in open capillary tubes and are uncorrected. IR spectra were measured on a JASCO FT/IR 4100 spectrometer and are reported in cm −1 .
NMR spectra were measured on commercial spectrometers operating at 600 MHz and 400 MHz for 1 H and 125 MHz for 13 C. Mass spectrometry was performed using a JEOL AccuTOF electrospray instrument (ESI †) or on a Bruker 12T Apex IV FT-ICR mass spectrometer. Compound 1a. A solution of dimethylglycoluril bis(cyclic ether) 1CE (0.650 g, 2.56 mmol) in TFA (7 mL) was mixed with compound 5 (3.96 g, 10.2 mmol). The mixture was stirred and heated at 70°C for 3 h and then was poured into MeOH (70 mL). The solid was collected by filtration and was dried under high vacuum. The crude solid was recrystallized two times from a mixture of water and acetone (1 : 2, v/v, 20 mL). The solid was dissolved in water (10 mL) and adjusted to pH = 7 by adding 1 M aqueous NaOH. The solvent was removed by rotary evaporation and then the solid was further dried under high vacuum to yield compound 1a (2.16 g, 83%) 
1612).
Compound 1b. A solution of dimethylglycoluril bis(cyclic ether) 1CE (0.650 g, 2.56 mmol) in TFA (7 mL) was mixed with compound 6 (4.57 g, 10.2 mmol). The mixture was stirred and heated at 70°C for 3 h and then was poured into MeOH (70 mL). The solid was collected by filtration and was dried under high vacuum. The crude solid was recrystallized twice from a mixture of water and acetone (1 : 2, v/v, 20 mL). The solid was dissolved in water (10 mL) and adjusted to pH = 7 by adding 1 M aqueous NaOH. The solvent was removed by rotary evaporation and then the solid was further dried under high vacuum to yield compound 1b (2.60 g, 91%) as a white solid. 2875w, 1722s, 1468m, 1440s, 1376m, 1302s, 1232m, 1093m, 1067m, 1001m, 949m, 917m, 881m, 768m, 737m, 668w . 11.0, 4H), 4.87 (d, J = 11.0, 4H), 4.33 (d, J = 15.8, 2H), 1.83 (s, 6H), 1.65 (s, 6H) . 13 C NMR (125 MHz, 76.4, 72.2, 70.6, 44.3, 17.9, 16.7 (3.996 g, 15.7 mmol) was added at once. The reaction mixture was stirred at 8-12°C for 2 h and then the ice bath was removed at the reaction was stirred at room temperature for another 2 h. The reaction was poured into precooled (5°C) acetone (700 mL) and the resulting precipitate was obtained by filtration. The solid was washed with about 100 mL acetone and then transferred while still wet into a mixture of acetonitrile and water (1 : 1 (v : v), 100 mL) and sonicated. The resulting precipitate was filtered and suspended in formic acid (2 mL). Finally the solid was thoroughly dried on the frit, washed with water and methanol and dried under vacuum to give 3CE as a white solid (204 mg, 0.332 mmol, 4%). M.p. >300°C. IR (ATR, cm −1 ): 3551w, 3455w, 3384w, 2990w, 2949w, 1718s, 1702s, 1656w, 1465m, 1425m, 1315s, 1271m, 1239s, 1181m, 1074m, 1013s, 918m, 851s, 788m, 735m, 663w . 2, 154.8, 154.7, 77.1, 72.4, 70.5, 69.9, 48.5, 17.7, 15.7 O (1 : 1 (v : v) , 8.0 mL). Compound 5 (916 mg, 2.30 mmol) was added. The reaction was stirred and heated in a preheated oil bath for 3 h at 70°C. Then the mixture was poured into acetone (75 mL). The precipitate was collected by centrifugation. The solid was dissolved in water (10 mL) and precipitated by the addition of EtOH (75 mL). The precipitate was collected by centrifugation, then redissolved in water (40 mL) and reprecipitated by the addition of acetone (120 mL). The precipitate was collected by filtration, dissolved in water and the pH of the solution adjusted to 7 by addition of 1 M aqueous NaOH. The solvent was removed under reduced pressure and the residue dried under vacuum. Compound 2a was obtained as brownish solid (533 .5, 150.9, 128.9, 116.7, 79.4, 77.5, 70.3, 48.8, 44.3, 35.5, 25.3, 16 O (1 : 1 (v : v) , 6.5 mL). Compound 6 (1.79 g, 4.00 mmol) was added and the reaction mixture stirred and heated for 3 h at 75-80°C in a pre-heated oil bath. The solution was poured into MeOH (75 mL) and filtered. The residue was dissolved in water (10 mL) and then acetone (50 mL) was added. The precipitate was obtained by filtration and then dissolved in water. The pH of the solution was adjusted to 7 by the addition of 1 M aqueous NaOH. The solvent was removed under reduced pressure and the residue was dried in high vacuum yielding compound 2b as an offwhite solid (752 mg, 0.57 mmol, 57% 127.4, 123.4, 78.8, 77.4, 74.0, 48.7, 44.0, 36.5, 25.9, 16.5, 16.4 O (1 : 1 (v : v) , 20.8 mL) compound 5 (1.37 g, 3.44 mmol) was added. The mixture was stirred and heated at 75-80°C for 3 h and then poured into MeOH (75 mL). The solid was collected by centrifugation. The residue was washed twice with MeOH (45 mL) and dried under vacuum. The off-white solid was dissolved in water and the pH was adjusted to 7 by addition of 1 M aqueous NaOH. The solvent was removed under reduced pressure. The residue was mixed with acetone (100 mL) and the solid collected by centrifugation. The solid was washed once with acetone (45 mL) and MeOH (45 mL) and then dissolved in water. The pH was checked to be at 7. The solvent was removed under reduced pressure and the residue dried under vacuum to yield compound 3a as a yellow solid (983 mg, 0.715 mmol, 48%). M.p. >300°C. IR (ATR, cm −1 ): 3444w, 2941w, 1713s, 1466s, 1380w, 1316m, 1237m, 1183s, 1091m, 1037s, 976w, 922w, 841m, 789m, 729w, 593m 150.9, 128.8, 116.0, 79.6, 78.3, 71.8, 69.7, 49.0, 48.9, 35.6, 25.3, 16.6, 15.8 Compound 3b. Compound 3CE (614.6 mg, 1.00 mmol) was dissolved in TFA-Ac 2 O (1 : 1 (v : v), 6.5 mL). Compound 6 (1.79 g, 4.00 mmol) was added and the reaction mixture stirred and heated for 3 h at 72-80°C in a pre-heated oil bath. The suspension was filtered using a glass frit and the residue washed with MeOH. The solid was dissolved in water (20 mL) and precipitated by the addition of acetone (80 mL). The precipitate was obtained by filtration, and the solid was washed with acetone and then dissolved in water. The pH of the solution was adjusted to 7 by addition of 1 M aqueous NaOH. The solvent was removed under reduced pressure. Finally, the yellowish solid was dried under vacuum to yield compound 3b as a yellowish solid (867 mg, 58.8 mmol, 59%). M.p. >300°C, IR (ATR, cm −1 ): 3441w, 2943w, 2881w, 1716s, 1465s, 1382w, 1345m, 1313m, 1177s, 1079m, 1035s, 950m, 881w, 827m, 788m, 724m, 668m .5, 156.9, 148.8, 128.6, 128.5, 127.6, 123.8, 79.4, 78.1, 74.7, 71.6, 48.8, 36.9, 26.0, 16.5, 16 
